Related Experiment Video
Updated: Jul 10, 2025
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?
Amanda A Myers1, Alberto Briganti2, Bradley Leibovich3
1Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Context:
Lymphadenectomy during surgery for genitourinary malignancies has varying benefits.
Objective:
To review contemporary evidence on lymph node dissection in genitourinary cancers.
Evidence Acquisition:
We performed a collaborative review to summarize current evidence supporting lymph node dissection in urothelial, prostate, kidney, penile, and testis cancers. We present the evidence on patient selection and recommended dissection templates, and highlight knowledge gaps and ongoing areas of investigation.
Evidence Synthesis:
Lymph node dissection remains the reference standard for lymph node staging. Pathologic nodal stage informs prognosis and guides adjuvant treatment. Appropriate template and patient selection are paramount to optimize outcomes and capitalize on the selective therapeutic benefits.
Conclusions:
Accurate staging with lymphadenectomy is contingent on appropriate template selection. The cumulative benefit will depend on judicious patient selection.
Patient Summary:
We performed a collaborative review by a diverse group of experts in urology. We reviewed current evidence on lymph node dissection.
More Related Videos
05:52Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
06:39Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Published on: November 22, 2019